$899 – $2,899

International Conference on Digital Health (CSE) A

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

Houston, USA

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

International Conference on Digital Health

About

Conference series llc ltd, extend a warm welcome to the distinguished Nobel laureates, speakers, delegates, digital health specialists, healthcare communities, digital health physicians, and Healthcare Industries ,leaders from around the world to Houston, USA, for attending International Conference on Digital Health during April 24-25,2019

Details on Digital Health 2019

|Conference Series llc ltd Houston USA| April 24-25

The use of modern technologies and digital services is not only changing the way we communicate, they also offer us innovative ways for monitoring our health and well-being.

By innovating in digital health and care we can support our ambition towards reducing inefficiencies in healthcare delivery, improving access, reducing costs, increasing quality of care, making our health services more person-centred, personalising medicine for each patient’s unique needs. It gives people the opportunity to be provided with ‘smart care’ in a homely environment so that they could live in an independent style.

Digital health 2019 will explore the topics in detail, with an eye towards providing benefits and wellness leaders with practical guidance they can use to get the most out of digital health.

Our mission at Digital Health 2019 is to make healthcare massively better for every human being. This event will support business leaders at the forefront of healthcare through our in-depth research and actionable insights to help navigate the most topical challenges impeding healthcare innovation.

This event will draw hundreds of innovative thinkers across healthcare, technology, venture capital, and beyond to confront the most challenging dilemmas in healthcare—and uncover new solutions. Our goal is to fill the gap between individuals and enterprises committed to advancing impactful innovation.

Digital Health 2019 will warmly welcome senior leaders from major healthcare companies—along with selected investors, academics, and startup founders—that explore best practices, deliver practical tools, and disseminate useful information to industry leaders around the topic of Digital tech in healthcare. This Two-day event will include a diverse series of talks, Keynote speech, skill-based workshops with leaders working at the forefront of healthcare innovation.

Target Audience

The aim of the conference is to bring together a multidisciplinary spectrum of researchers, industry/start-ups and healthcare practitioners. Submissions are welcome from the range of stakeholders involved in digital health including:

Health informaticians , Computer scientists, emergency medicine experts
Public health experts, epidemiologists, clinicians, GPs
National and international public Health Agencies
Epidemic intelligence systems providers
NGOs and Agencies
Industry and startups, Med tech, IT/SM industry, pharmaceutical industry

Scientific Sessions and Tracks

Track-1Digital Health Start-up Forum

Due to advancement of healthcare technologies, a number of start-up Companies utilises digital and Internet-based health technologies to make behavioural and lifestyle changes in patients. A number of start-up Companies based on Digital Health Therapeutics, telehealth, Digital Pathology, Digital health, e Health, mHealth Companies are being promoted with their latest innovative methodologiesthat uses digital implements like mobile-devices, apps, sensors, etc to spur behavioural changes in patients.

Market Analysis

In 2016, the global digital health market was at $179.6 billion, according to Transparency Market Research (TMR). Growth in this market is anticipated to rise at a CAGR of 13.4% between 2017 and 2025, reaching $536.6 billion by the end of 2025. Over the next few years, TMR says the market will be supported by technology advancements in the medical and healthcare infrastructure.

Track 2- m Health
m-Health is defined as the medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistances and other wireless devices. mHealth is already being used to monitor a variety of conditions including heart disease, diabetes, autism, insomnia and asthma. The WHO/ITU programme aims to assist governments to use mobile components to reinforce their existing national health activities to prevent, manage, and treat non-communicable diseases (NCDs) and their risk factors.

Benefits include:

Reduction in health spending
Healthy population
Adoption of existing mHealth services
Opportunities for Research and Development
Demonstrates commitment to achieving NCD reduction targets

Global mHealth Market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. The mHealth market is in its nascent stage and is expected to yield significant revenues with increasing awareness and favorable regulatory impositions specific to the quality and feasibility of mobile-based medical devices. Penetration of mobile phones in healthcare segment has had a significant impact on the overall healthcare industry.

Track 3. e-Health

e- health encompasses much of medical informatics but tends to prioritise the delivery of clinical information, care and services rather than the functions of technologies. Throughout many western national healthcare services, extensive e-Health infrastructures and systems are now viewed as central to the future provision of safe, efficient, high quality, citizen-centred health care. e- Health market growth is attributed to the transition of the healthcare industry into the digital healthcare system for patient’s management and analysis of health.

The global electronic health (e Health) market is growing at a swift pace and is projected to witness robust growth in the coming years. Technological developments, innovations, and the use of electronic devices are augmenting the global e Health market. The increasing adoption of these systems by medical practitioners across the globe is anticipated to offer promising opportunities for prominent players in the market. Global e Health market is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market.

Track-4. Digital Health Technologies

Catagories that come under this group include:

Artificial Intelligence
Sleep Tech
Psycological Technology

Track-5.Medical Informatics and Telemedicine

Medical informatics means the application of computers, communications and information technology and systems in all fields of medicine - medical care, medical education and medical research. The definition of Medical Informatics is a new, exciting and evolving field. New specialties and careers are now possible in this field. The expectation is that information technology will improve medical quality, patient safety, educational resources and patient-physician communication, while decreasing cost. Applied Medical Informatics studies the dispensation of medical statistics, the potent, management of information using computer technology, and the impact of such methods on medical research, education.

Telemedicine is the use of telecommunication and information technologies to provide clinical and medical health care at a distance. It helps to eliminate distance barriers and can improve access to clinical services that would often not be consistently available in distant rural communities. It is also used to save lives in critical care and emergency situations. Although there were distant precursors to telemedicine, it is essentially a product of 20th century telecommunication and information technologies. These technologies permit communications between patient and medical staff with both convenience and loyalty, as well as the transmission of medical, imaging and health informatics data from one site to another. It is a process for accurate data collection in digital format and an electronic medical record for data incorporation .Remote transmission Telemedicine is a system for automatically flagging and providing feedback for outlier data.

Track 6.Drug Discovery & Drug Screening

Preclinical development envelops the exercises that connection sedate disclosure in the lab to start of human clinical trials. Preclinical investigations can be intended to distinguish a lead hopeful from a few hits; build up the best methodology for new medication scale-up; select the best formulation; decide the course, recurrence, and span of introduction; and at last help the proposed clinical trial plan. Simultaneous preclinical development exercises incorporate building up a clinical arrangement and setting up the new medication item, including related documentation to meet stringent FDA Great Assembling Practices and administrative rules.

Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified.

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

Track -7.Diabetes and digital health

Diabetes care is largely dependent on patient self‐management and empowerment, given that patients with diabetes must make numerous daily decisions as to what to eat, when to exercise, and determine their insulin dose and timing if required. In addition, patients and providers are generating vast amounts of data from many sources, including electronic medical records, insulin pumps, sensors, glucometers, and other wearables, as well as evolving genomic, proteomic, metabolomics, and microbiomic data. Multiple digital tools and apps have been developed to assist patients to choose wisely, and to enhance their compliance by using motivational tools and incorporating incentives from social media and gaming techniques. Healthcare teams (HCTs) and health administrators benefit from digital developments that sift through the enormous amounts of patient‐generated data.

The prevalence of diabetes is continuing to grow year on year across the world. The increase in demand for services is not sustainable, and it is widely recognised within the health and care system that transformational change is required. One practical implication of this is that patients, their families and carers will need to be more actively involved in the prevention and management of diabetes. There is a growing body of international evidence that this can effectively be supported by technology, while at the same time improving patient satisfaction with their care.

There have also been significant advances in digital solutions to support self-management for glucose monitoring and control, proper medicine use and lifestyle management. Virtual clinics have been trialled and several health boards are using home and mobile health monitoring solutions for the day to day management of diabetic patients.

Progression in both glucose monitoring and insulin delivery technologies are enabling the delivery of a previously conceptual artificial pancreas system, able to deliver controlled insulin doses, based on sensor outputs to optimise glucose levels. The market for these fully automated diabetes management systems is expected to reach $6.5 billion by 2027.

Track 8.Digital Therapeutics & Diagnostics

Digital Therapeutics is a health treatment procedure that involves both digital and online Health Technologies to treat a certain medical condition. Digital therapeutics have generated a great deal of recent attention throughout the healthcare industry, with the potential to induce lifestyle changes, enhance the treatments and reduce healthcare costs. Digital therapeutics, also known as “software as a drug”, uses digital technologies such as apps, devices and software for the treatment of patients similar as the drugs, surgeries or medical devices do therapeutically.

The global digital therapeutics market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth.

Track 9.Clinical Research & Clinical Trials

Clinical Trial is a part of clinical research that follows a regulated protocol or a plan of action. They are primarily performed to get data on safety and efficacy of the new developed drug , this data is mandatory for further approval of the drug and to bring it to the market.

The clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials. Clinical studies can be sponsored, or funded, by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations, in addition to Federal agencies such as the National Institutes of Health, the U.S. Department of Defense, and the U.S. Department of Veterans Affairs. Doctors, other health care providers, and other individuals can also sponsor clinical research.

Track-10. Ethical and Policy Challenges in Digital Health

We know that healthcare is on the verge of a paradigm shift due to the appearance of technologies such as artificial intelligence, health sensors or robotics . New kinds of global markets for healthcare and healthcare data are emerging, and responsibility for health and well-being seems to be devolving onto the data-equipped individual. Coupled to political claims of digital ‘revolutions’ and ‘disruptions’ in healthcare policy, the digital transformation of healthcare also marks a shift in the terms on which political economic and ethical decisions about health are made in the context of the sustainability of national health systems, whether by a patient, a clinician or a commissioner. Digital technologies promise smart, convenient and personalisable servicing of individual healthcare needs, but at the same time they threaten significant changes around the ethics of privacy, around evidence-based ‘data driven’ policy formation and around organisational reform affecting patients and medical professionals, amongst other things.

Track-11. Bioinformatics and Digital Health

Nowadays, it goes without saying that the use of information technology is important, even necessary, in the field of life sciences.

The amount of information that needs to be processed, analysed, stored, and represented is constantly growing. These data must then be integrated, compared, and viewed alongside other data to further knowledge and generate added value. Even beyond the issues presented by managing data and the effort required to process this information, the challenge is to improve the capacity of researchers to develop new hypotheses, produce innovative models, and test them.

Bio-Informatics and Information Management professionals are experts in managing the collection, storage, retrieval, analysis and interpretation of health care data and information. To provide the highest quality health care delivery, health care information is used not only for patient care, but also for medical legal issues, reimbursement, research, planning and evaluation. Opportunities for employment are found in a variety of settings, including hospitals, clinics, rehabilitation centers, home health agencies, health maintenance organizations, insurance agencies, governmental agencies, educational institutions and research centers.

Track-12. Genomics & Precision Medicine

Precision medicine makes use of variations in consumers genes, environment, and lifestyle to guide the prevention, diagnosis, and treatment of diseases. The potential for precision medicine to radically transform the healthcare industry is driving interest among a range of companies and government organizations. . Firms are flocking to develop the tools needed to extract, store, share, and analyze genomic data. The global precision medicine market is expected to grow at an annualized rate of 12% over 7 years to reach $88.6 billion by 2022, up from $39 billion in 2015, according to Market Research Future.

Track-13. Digital Healthcare and Womens Health

Fem tech is hailed as the next big phenomenon in the women’s health market and the time has come for clinical diagnostics, bio-pharmaceuticals, and medical device companies to tap into this market opportunity. Fem tech (female technology) refers to software, diagnostics, products, and services that use technology to improve women’s health. Fem tech involves the use of digital health to motivate patients to access and use applications for managing women’s health issues.

The past few years have seen the rise of Fem tech, mainly due to higher funding and also because of a conducive regulatory environment that has seen the approval of new-age digital applications for Femtech. Personalized wellness and consumer healthcare technology has been a top-5 investment area in digital health for several years now, and Fem tech has brought in overall funding of approximately $1 billion since 2014. Since 2016, regulatory agencies have also approved digital applications for conventional women’s health issues and this has paved the way for Fem tech applications in the mainstream market.

Track-14. Big Data and Digital Transformation

Big Data and analytics is an integral part of digital transformation .Many organisations have undergone a digital transformation to adapt the ever-changing digital landscape. They are achieving transformation through their control over Big Data and Analytics, and by using Machine Learning technology. Big data offers organisations the chance to learn more than what has ever been possible about what their customers want. Many health plans still rely on legacy technologies to power their business. This makes them vulnerable to customer-centric, tech-enabled newcomers. But IT leaders have a window of opportunity to unlock system data, enabling care orchestration.

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

VIO180907CRE

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

Houston, USA

View Map

Refund Policy

No Refunds

Save This Event

Event Saved